Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 75 peer-reviewed journal articles Updated
Medical Genetics

Understanding Bardet-Biedl Syndrome: A Guide for Patients and Families

At a Glance

Bardet-Biedl Syndrome (BBS) is a rare genetic disorder affecting how your cells communicate. It causes symptoms like vision changes, extra digits, and rapid weight gain. Multidisciplinary care and new targeted treatments like Setmelanotide can help manage symptoms effectively and improve health.

Receiving a diagnosis of Bardet-Biedl Syndrome (BBS) can feel overwhelming and isolating. For many patients and families, this moment marks the end of a long “diagnostic odyssey”—a period of searching for answers across multiple doctors and tests [1][2]. It is common to feel a mix of relief that the search is over and anxiety about what the future holds. Because BBS is rare, your local doctors may not be familiar with it, and finding specialized care is a critical next step [3][4].

Understanding the “Cellular Antenna”

To understand BBS, it helps to think about how the cells in your or your child’s body communicate. Most cells have a tiny, hair-like structure on their surface called a primary cilium [5]. You can think of this cilium as a “cellular antenna” that receives signals from the rest of the body [6].

BBS is classified as a non-motile ciliopathy—a condition where these cellular antennas do not move but are essential for sensing the environment [5][7]. In individuals with BBS, a group of proteins (often called the BBSome) fails to build or operate these antennas correctly [8]. When the antennas cannot send or receive signals properly, it affects multiple systems in the body, leading to the various symptoms associated with the syndrome [9][6].

How Rare is BBS?

BBS is a rare condition, though its frequency varies significantly depending on where you live.

  • Global Prevalence: It is estimated to affect approximately 1 in 125,000 to 1 in 160,000 people worldwide [10][11].
  • Regional Differences: In Europe and the United States, the rate is often reported as lower than 1 in 100,000 [10].
  • Higher Prevalence Areas: In certain populations with a history of “founder effects” (where a small group starts a new population) or high rates of consanguinity (parents who are related), the condition is much more common. For example, on La Réunion Island, the rate is estimated between 1 in 45,000 and 1 in 66,000 [12][13].

Because the condition is so rare, specialized genetic testing is often required to confirm which of the many known BBS genes is involved [14][15].

Navigating the Diagnostic Odyssey

Many individuals and families spend years visiting different specialists for seemingly unrelated symptoms—such as extra fingers or toes (polydactyly), vision changes, or rapid weight gain—before a unifying diagnosis is made [16][17]. This journey can be emotionally and logistically draining.

Current medical consensus highlights that an early and accurate diagnosis is vital [18][19]. Recent European guidelines have updated the diagnostic criteria to help doctors identify the syndrome more reliably through a combination of clinical features and genetic confirmation [3]. Recognizing the syndrome early allows for proactive monitoring of the kidneys, eyes, and metabolic health [20][21].

Stabilizing Facts for Patients and Families

While the diagnosis is life-changing, there are stabilizing truths to hold onto as you move forward:

  1. A Clear Roadmap Exists: There are now established clinical frameworks and multidisciplinary teams specifically trained to manage BBS [3][5].
  2. Management is Progressive: BBS is a multisystem condition, meaning it affects different parts of the body at different times [22]. Care focuses on long-term monitoring and managing symptoms as they arise [4].
  3. New Treatments are Emerging: Research has led to the development of targeted therapies. For instance, Setmelanotide is now an approved medication for patients ages 6 and older to help manage the intense hunger (hyperphagia) and obesity often associated with BBS [23][24].
  4. You are Not Alone: Patient-led rare disease organizations and specialized networks provide a community of support and access to the latest research [25][3].

Early intervention and a dedicated care team can significantly improve quality of life and long-term health outcomes [19][26].

In this guide

5 chapters

01

Symptoms and the Path to Diagnosis: The Beales Criteria

Learn how Bardet-Biedl syndrome (BBS) is diagnosed using the Beales criteria. Understand primary and secondary symptoms and the timeline of disease progression.

02

The Biology of BBS: Cellular Antennas and Genetics

Learn the biology behind Bardet-Biedl Syndrome (BBS). Understand how cellular antennas, BBSome mutations, and specific genes impact your health and care.

03

Protecting Vision and Kidney Health in BBS

Learn how Bardet-Biedl Syndrome (BBS) affects vision and kidneys. Understand rod-cone dystrophy, eGFR testing, and proactive monitoring to protect your health.

04

Managing Hunger and Weight: The Science of Hyperphagia

Learn why Bardet-Biedl Syndrome causes hyperphagia (constant hunger). Discover how targeted treatments like setmelanotide (Imcivree) help manage BBS weight.

05

Building Your Care Team and Staying Proactive

Learn how to build a multidisciplinary care team for Bardet-Biedl syndrome (BBS). Discover the annual surveillance schedule and how to manage adult care.

Common questions in this guide

What causes Bardet-Biedl syndrome?
Bardet-Biedl syndrome is caused by problems with a group of proteins called the BBSome. These proteins help build and operate the primary cilium, which acts as a cellular antenna. When this antenna fails, it affects how cells communicate, leading to the various symptoms of BBS.
How rare is Bardet-Biedl syndrome?
BBS is a very rare condition that affects approximately 1 in 125,000 to 1 in 160,000 people worldwide. However, it can be more common in certain populations or regions due to shared genetic backgrounds.
What are the first signs of Bardet-Biedl syndrome?
Initial signs often include being born with extra fingers or toes, a condition known as polydactyly. Families and doctors may also notice rapid childhood weight gain, intense hunger, and early vision changes.
Which doctors should I see for a BBS diagnosis?
Because BBS affects multiple body systems, you will need a specialized multidisciplinary care team. This typically includes a medical geneticist to review tests, an ophthalmologist for vision care, and a nephrologist to monitor kidney function.
Are there any treatments for Bardet-Biedl syndrome?
While there is currently no cure for BBS, symptoms can be managed through a team of specialists. There are also targeted therapies available, such as Setmelanotide, which is an approved medication used to help control intense hunger and severe obesity in eligible patients.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific genetic variant was identified in my or my child's test results, and how does it affect the course of the syndrome?
  2. 2.What multidisciplinary specialists (nephrology, ophthalmology, genetics) should we see immediately for a baseline evaluation?
  3. 3.Are there specialized centers of excellence or rare disease networks for BBS that you recommend we connect with?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (26)
  1. 1

    Caring for a child with Bardet-Biedl syndrome: A qualitative study of the parental experiences of daily coping and support.

    Zelihić D, Hjardemaal FR, Lippe CV

    European journal of medical genetics 2020; (63(4)):103856 doi:10.1016/j.ejmg.2020.103856.

    PMID: 31972368
  2. 2

    Rarity of Laurence Moon Bardet Biedl Syndrome and its Poor Management in the Pakistani Population.

    Khan OA, Majeed R, Saad M, et al.

    Cureus 2019; (11(2)):e4114 doi:10.7759/cureus.4114.

    PMID: 31058008
  3. 3

    Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations.

    Dollfus H, Lilien MR, Maffei P, et al.

    European journal of human genetics : EJHG 2024; (32(11)):1347-1360 doi:10.1038/s41431-024-01634-7.

    PMID: 39085583
  4. 4

    Unveiling the Spectrum of Otorhinolaryngological Manifestations in Siblings With Bardet-Biedl Syndrome: A Report of Two Cases.

    Padmanabhan K, Ashish S, Vijayan N, Hemanthkumar SM

    Cureus 2024; (16(8)):e66233 doi:10.7759/cureus.66233.

    PMID: 39238742
  5. 5

    Monitoring and Management of Bardet-Biedl Syndrome: What the Multi-Disciplinary Team Can Do.

    Caba L, Florea L, Braha EE, et al.

    Journal of multidisciplinary healthcare 2022; (15()):2153-2167 doi:10.2147/JMDH.S274739.

    PMID: 36193191
  6. 6

    BBS8-dependent ciliary Hedgehog signaling governs cell fate in the white adipose tissue.

    Sieckmann K, Winnerling N, Silva Ribeiro DJ, et al.

    The EMBO journal 2025; (44(19)):5315-5336 doi:10.1038/s44318-025-00524-y.

    PMID: 40836034
  7. 7

    Clinical characteristics of individual organ system disease in non-motile ciliopathies.

    Grochowsky A, Gunay-Aygun M

    Translational science of rare diseases 2019; (4(1-2)):1-23 doi:10.3233/TRD-190033.

    PMID: 31763176
  8. 8

    Hydrometrocolpos and postaxial polydactyly in a girl newborn: A case report.

    Day ML, Avila CC, Novak DL

    Clinical case reports 2022; (10(2)):e05453 doi:10.1002/ccr3.5453.

    PMID: 35223016
  9. 9

    Bardet-Biedl syndrome: a rare cause of end-stage kidney disease. Case report.

    Bouchoual M, Dadi K, Cherradi I, et al.

    Annals of medicine and surgery (2012) 2025; (87(7)):4636-4639 doi:10.1097/MS9.0000000000003434.

    PMID: 40852023
  10. 10

    Bardet-Biedl Syndrome With Renal, Cardiac, and Genitourinary Malformations: A Case Report.

    Waleed MS, Varughese AA, Amba V, Pathalapati R

    Cureus 2021; (13(12)):e20577 doi:10.7759/cureus.20577.

    PMID: 35103156
  11. 11

    Ciliopathy: Bardet-Biedl Syndrome.

    Hondur A, Tsang S, Aycinena ARP, et al.

    Advances in experimental medicine and biology 2025; (1467()):185-188 doi:10.1007/978-3-031-72230-1_33.

    PMID: 40736835
  12. 12

    High prevalence of Bardet-Biedl syndrome in La Réunion Island is due to a founder variant in ARL6/BBS3.

    Gouronc A, Zilliox V, Jacquemont ML, et al.

    Clinical genetics 2020; (98(2)):166-171 doi:10.1111/cge.13768.

    PMID: 32361989
  13. 13

    A Beacon of Hope: Confronting Bardet-Biedl Syndrome in Pakistan's Health Care Frontier.

    Ahmad Mian D, Shah ZA, Ikram MT, et al.

    AACE clinical case reports 2025; (11(2)):121-125 doi:10.1016/j.aace.2024.12.006.

    PMID: 40201460
  14. 14

    Homozygous Pathogenic Variant in BBS9 Gene: A Detailed Case Study of Bardet-Biedl Syndrome.

    Al-Mat'hammi AA, Alzahrani SA, Alsefry FS, et al.

    Cureus 2024; (16(7)):e65774 doi:10.7759/cureus.65774.

    PMID: 39211725
  15. 15

    Kidney failure in Bardet-Biedl syndrome.

    Meyer JR, Krentz AD, Berg RL, et al.

    Clinical genetics 2022; (101(4)):429-441 doi:10.1111/cge.14119.

    PMID: 35112343
  16. 16

    Bardet-Biedl Syndrome-Multiple Kaleidoscope Images: Insight into Mechanisms of Genotype-Phenotype Correlations.

    Florea L, Caba L, Gorduza EV

    Genes 2021; (12(9)) doi:10.3390/genes12091353.

    PMID: 34573333
  17. 17

    Bardet-Biedl syndrome: Delayed diagnosis in a 14-year-old child with end-stage renal disease.

    Rasel M, Istiak A, Saiara A, et al.

    Clinical case reports 2023; (11(7)):e7649 doi:10.1002/ccr3.7649.

    PMID: 37415582
  18. 18

    Delayed identification of Bardet-Biedl syndrome.

    Kanitkar S, Ande SP, Shivnitwar SK, Edara M

    BMJ case reports 2024; (17(11)) doi:10.1136/bcr-2024-261843.

    PMID: 39542505
  19. 19

    Bangladeshi Case Series of Bardet-Biedl Syndrome.

    Osman F, Iqbal MI, Islam MN, Kabir SJ

    Case reports in ophthalmological medicine 2023; (2023()):4017010 doi:10.1155/2023/4017010.

    PMID: 37096247
  20. 20

    A rare case of Bardet-Biedl syndrome.

    Shrinkhal , Singh A, Agrawal A, et al.

    Taiwan journal of ophthalmology 2020; (10(2)):138-140 doi:10.4103/tjo.tjo_62_19.

    PMID: 32874845
  21. 21

    Multiallelic Rare Variants in BBS Genes Support an Oligogenic Ciliopathy in a Non-obese Juvenile-Onset Syndromic Diabetic Patient: A Case Report.

    Dallali H, Kheriji N, Kammoun W, et al.

    Frontiers in genetics 2021; (12()):664963 doi:10.3389/fgene.2021.664963.

    PMID: 34691137
  22. 22

    Bardet-Biedl Syndrome in an Ethiopian.

    Tsegaw A, Teshome T

    International medical case reports journal 2021; (14()):177-181 doi:10.2147/IMCRJ.S299421.

    PMID: 33776488
  23. 23

    Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.

    Haqq AM, Chung WK, Dollfus H, et al.

    The lancet. Diabetes & endocrinology 2022; (10(12)):859-868 doi:10.1016/S2213-8587(22)00277-7.

    PMID: 36356613
  24. 24

    Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet-Biedl syndrome: phase 3 trial results.

    Forsythe E, Haws RM, Argente J, et al.

    Orphanet journal of rare diseases 2023; (18(1)):12 doi:10.1186/s13023-022-02602-4.

    PMID: 36647077
  25. 25

    Engaging patient-led rare disease organizations to advance research - through the lens of Bardet-Biedl syndrome.

    Ogden T, de Graaf B, Hymers T

    Journal of cell science 2025; (138(20)) doi:10.1242/jcs.264320.

    PMID: 41140280
  26. 26

    Next-Generation Sequencing in the Diagnosis of Patients with Bardet-Biedl Syndrome-New Variants and Relationship with Hyperglycemia and Insulin Resistance.

    Jeziorny K, Antosik K, Jakiel P, et al.

    Genes 2020; (11(11)) doi:10.3390/genes11111283.

    PMID: 33138063

This guide provides general information about Bardet-Biedl Syndrome (BBS) for educational purposes. Always consult with your medical genetics team or healthcare provider to discuss your specific symptoms and treatment plan.

Get notified when new evidence is published on Bardet-Biedl syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.